Equities

Biotricity Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BTCY:QBB

Biotricity Inc

Actions
  • Price (USD)0.2767
  • Today's Change0.027 / 10.68%
  • Shares traded22.18k
  • 1 Year change-30.81%
  • Beta1.3842
Data delayed at least 15 minutes, as of Feb 06 2026 18:26 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Biotricity Inc. is a medical technology company focused on biometric data monitoring solutions. The Company developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patient’s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The Company has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.

  • Revenue in USD (TTM)15.08m
  • Net income in USD-4.87m
  • Incorporated2012
  • Employees46.00
  • Location
    Biotricity Inc203 Redwood Parkway, Suite 600REDWOOD CITY 94065United StatesUSA
  • Phone+1 (650) 832-1626
  • Websitehttps://www.biotricity.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dalrada Financial Corp18.37m-23.89m4.81m0.00------0.2616-0.2172-0.21720.1626-0.13030.90894.865.34---118.42-100.15-1,575.08-1,511.4525.5728.94-130.29-92.980.2685-6.36----2.3276.7114.86--15.56--
Innovative Eyewear Inc2.39m-7.85m5.26m11.00--0.4993--2.20-2.63-2.630.73691.970.21011.4529.13217,504.50-68.92-143.06-73.91-176.8022.844.06-327.98-574.8910.13--0.00--41.99220.75-16.55------
iTonic Holdings Ltd305.22k-2.41m6.05m10.00--1.28--19.83-0.1637-0.16370.02150.27750.09430.62922.0230,522.00-74.52---100.07--82.86---790.56--11.36--0.0287---28.70---173.85------
STRATA Skin Sciences Inc30.98m-11.04m6.06m106.00--4.13--0.1958-2.62-2.627.290.24940.87364.517.80292,264.20-31.13-14.64-52.77-21.5157.7659.75-35.64-21.510.746-4.020.921--0.61161.226.87---10.13--
Kelyniam Global Inc-100.00bn-100.00bn6.19m0.00--8.41----------0.0146------------------------0.6993--0.3831--------------
ADM Tronics Unlimited Inc3.36m-129.58k6.32m7.00--7.1817.971.88-0.0019-0.00190.04970.0131.474.956.60---5.67-17.71-10.33-27.7539.0740.78-3.86-19.080.8633-3.740.3461--7.81-1.7285.97------
Biomerica Inc4.46m-4.03m6.86m53.00--1.51--1.54-1.64-1.641.761.500.672.543.9284,113.21-60.49-51.40-81.87-60.825.6111.63-90.29-71.362.29--0.00---1.92-4.5216.81---20.83--
Biotricity Inc15.08m-4.87m6.99m46.00------0.4635-0.1887-0.18870.5821-1.172.601.498.38327,858.70-77.97-229.45----79.8464.92-30.02-184.400.1389-0.1077----14.3257.6120.01------
Scientific Industries Inc8.95m-1.24m7.04m67.00--0.5648--0.7861-0.1394-0.13890.80271.040.64261.538.80133,628.40-8.91---10.06--41.46---13.87--6.34--0.00---3.59--29.09------
Tenon Medical Inc3.23m-12.81m7.21m27.00--3.32--2.23-2.76-2.760.57250.55760.27631.562.96119,740.70-109.47-174.04-149.09-976.4552.4034.39-396.26-788.171.70--0.00--11.92127.6112.25------
Dror Ortho-Design Inc0.00-3.12m7.66m3.00---------0.0033-0.00330.00-0.00240.00----0.00-405.89-214.68---759.55-------276,220.70---69.87---------61.89------
Bioelectronics Corp1.61m-289.82k8.65m9.00------5.37-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
SeaStar Medical Holding Corp881.00k-13.67m8.69m19.00--0.7168--9.86-16.43-16.430.68743.360.0876--6.1046,368.42-135.86---290.37--95.35---1,551.08--3.64--0.00------5.34------
Beyond Air Inc5.80m-36.70m8.92m61.00--0.6573--1.54-7.54-7.541.151.590.13822.608.0195,114.76-89.86-81.28-105.60-103.40-6.70---650.33-4,167.723.73-16.500.4351--219.6721.6622.60--166.66--
HeartSciences Inc8.67k-9.04m8.96m15.00--2.07--1,033.74-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
AccuStem Sciences Inc0.00-1.61m9.18m2.00---------0.1163-0.11630.00-0.18110.00----0.00-192.46--------------------------26.60------
Data as of Feb 06 2026. Currency figures normalised to Biotricity Inc's reporting currency: US Dollar USD

Institutional shareholders

0.17%Per cent of shares held by top holders
HolderShares% Held
Strengthening Families & Communities LLCas of 30 Sep 202548.26k0.17%
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.